{
    "title": "FDA questions benefit of cystic fibrosis drug from Vertex",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3073623/FDA-questions-benefit-cystic-fibrosis-drug-Vertex.html",
    "date": "2015-05-08",
    "keywords": [
        "drug",
        "fibrosis",
        "improvement",
        "vertex",
        "ingredient",
        "orkambi",
        "benefit",
        "disease",
        "treatment",
        "percent",
        "foundation",
        "fda",
        "kalydeco",
        "lung",
        "press",
        "gmt",
        "washington",
        "health",
        "combination",
        "addition",
        "food",
        "administration",
        "online",
        "review",
        "breathing",
        "effect",
        "mucus",
        "buildup",
        "death",
        "school",
        "care",
        "patient",
        "today",
        "foundationvertexs",
        "brand",
        "name",
        "companys",
        "followup",
        "breakthrough",
        "cause",
        "lumacaftorbut",
        "lumacaftor",
        "panel",
        "tuesday",
        "agency",
        "lack",
        "drugorkambi",
        "form",
        "cluster",
        "company",
        "function",
        "measure",
        "meaningfulness",
        "magnitude",
        "body",
        "weight",
        "quality",
        "life",
        "questionnaire",
        "evidence",
        "effectfda",
        "morning",
        "trading",
        "friday",
        "price",
        "study",
        "functioncompany",
        "protein",
        "cell",
        "balance",
        "flow",
        "water",
        "chloride",
        "decision",
        "july",
        "partnership",
        "number",
        "specialty",
        "search",
        "research",
        "funding",
        "culminating",
        "approval",
        "twiceaday",
        "pill",
        "year",
        "cambridge",
        "massachusetts",
        "companylast",
        "royalty"
    ],
    "category": [
        "wires",
        "ap"
    ]
}